- Personal FinanceCompare Online BrokersTop StocksAlternative Investing
- CryptoGet StartedNFTs
Autolus Therapeutics (NASDAQ:AUTL), Quotes and News Summary
Autolus Therapeutics (NASDAQ: AUTL)
Earnings
see more| Q2 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2022-08-04 | ||||||
| REV | |||||||
| Q1 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.510 | -0.410 | 0.1000 | ||||
| REV | 250.000K | 166.000K | -84.000K |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
Autolus Therapeutics Questions & Answers
You can purchase shares of Autolus Therapeutics (NASDAQ: AUTL) through any online brokerage.
Other companies in Autolus Therapeutics’s space includes: Outlook Therapeutics (NASDAQ:OTLK), KalVista Pharmaceuticals (NASDAQ:KALV), Precigen (NASDAQ:PGEN), PepGen (NASDAQ:PEPG) and LianBio (NASDAQ:LIAN).
The latest price target for Autolus Therapeutics (NASDAQ: AUTL) was reported by Truist Securities on Tuesday, June 14, 2022. The analyst firm set a price target for 11.00 expecting AUTL to rise to within 12 months (a possible 300.00% upside). 1 analyst firms have reported ratings in the last year.
The stock price for Autolus Therapeutics (NASDAQ: AUTL) is $2.75 last updated July 1, 2022, 8:00 PM UTC.
There are no upcoming dividends for Autolus Therapeutics.
Autolus Therapeutics’s Q2 earnings are confirmed for Thursday, August 4, 2022.
There is no upcoming split for Autolus Therapeutics.
Autolus Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.